It has been hypothesized that the age-related increases in FGF21 are related to the appearance of an FGF21-resistant state, as has been proposed to occur in metabolic diseases such as obesity and type 2 diabetes [10, 29]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.